MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2018 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
2.1 M |
Market Cap[1] |
$ 654 K |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Heron Therapeutics
HRTX
|
$ 0.3 | 3.65 % | $ 50 M | Nasdaq Global Select Market,SPB | USA |
 |
Inovio Pharmaceuticals
INO
|
$ 1.63 | -1.81 % | $ 76.4 M | Nasdaq Global Select Market | USA |
 |
Corvus Pharmaceuticals
CRVS
|
$ 10.57 | 7.53 % | $ 835 M | Nasdaq Global Market | USA |
 |
Aytu BioScience
AYTU
|
$ 1.9 | -1.55 % | $ 23.4 M | Nasdaq Capital Market | USA |
 |
Heat Biologics, Inc.
HTBX
|
- | -5.76 % | $ 99.8 M | Nasdaq Capital Market | USA |
 |
Innoviva
INVA
|
$ 21.26 | 1.58 % | $ 1.43 B | Nasdaq Global Select Market | USA |
 |
BioCardia
BCDA
|
$ 0.91 | -1.26 % | $ 6.07 M | Nasdaq Global Select Market | USA |
 |
Kindred Biosciences, Inc.
KIN
|
- | 0.11 % | $ 419 M | Nasdaq Global Select Market | USA |
 |
Alterity Therapeutics Limited
ATHE
|
$ 2.5 | 1.21 % | $ 16 B | Nasdaq Capital Market |  Australia |
 |
Shineco, Inc.
TYHT
|
- | -3.90 % | $ 97.2 M | Nasdaq Global Select Market |  China |
 |
Millendo Therapeutics, Inc.
MLND
|
- | -5.36 % | $ 20.2 M | Nasdaq Global Select Market | USA |
 |
Certara
CERT
|
$ 11.09 | 1.98 % | $ 1.78 B | Nasdaq Global Select Market | USA |
 |
Dyadic International
DYAI
|
$ 0.37 | 1.44 % | $ 13.4 M | Nasdaq Capital Market | USA |
 |
Intec Pharma Ltd
NTEC
|
- | -12.45 % | $ 17.7 M | Nasdaq Capital Market |  Israel |
 |
Anika Therapeutics
ANIK
|
$ 20.37 | 4.73 % | $ 292 M | Nasdaq Global Select Market,SPB | USA |
 |
Aprea Therapeutics
APRE
|
$ 0.51 | -1.59 % | $ 3.33 M | Nasdaq Global Select Market,SPB | USA |
 |
Galectin Therapeutics
GALT
|
$ 3.49 | 4.18 % | $ 223 M | Nasdaq Global Select Market | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
$ 79.1 | -3.45 % | $ 8.22 B | Nasdaq Capital Market,SPB | USA |
 |
Progenity, Inc.
PROG
|
- | -3.47 % | $ 164 M | Nasdaq Global Select Market | USA |
 |
Genprex
GNPX
|
$ 2.16 | -6.49 % | $ 2.01 M | Nasdaq Capital Market | USA |
 |
Strongbridge Biopharma plc
SBBP
|
- | 1.52 % | $ 136 M | Nasdaq Global Select Market | USA |
 |
Innate Pharma S.A.
IPHA
|
$ 1.43 | 7.14 % | $ 128 M | Nasdaq Global Select Market |  France |
 |
Seneca Biopharma, Inc.
SNCA
|
- | -1.19 % | $ 28.7 M | Nasdaq Capital Market | USA |
 |
BioMarin Pharmaceutical
BMRN
|
$ 57.15 | 2.68 % | $ 11 B | Nasdaq Global Select Market,SPB | USA |
 |
Matinas BioPharma Holdings
MTNB
|
$ 1.16 | 3.12 % | $ 6.35 M | NYSE American | USA |
 |
Enanta Pharmaceuticals
ENTA
|
$ 10.69 | 3.09 % | $ 228 K | Nasdaq Global Select Market,SPB | USA |
 |
Milestone Pharmaceuticals
MIST
|
$ 0.78 | 3.19 % | $ 82.9 M | Nasdaq Global Select Market |  Canada |
 |
Kiniksa Pharmaceuticals, Ltd.
KNSA
|
$ 95.5 | 2.37 % | $ 7.09 B | Nasdaq Global Select Market | USA |
 |
Lipocine
LPCN
|
$ 1.43 | -2.05 % | $ 7.79 M | Nasdaq Global Select Market | USA |
 |
Seres Therapeutics
MCRB
|
$ 2.11 | 7.65 % | $ 18.7 M | Nasdaq Global Select Market | USA |
 |
Madrigal Pharmaceuticals
MDGL
|
$ 400.41 | 1.03 % | $ 8.98 B | Nasdaq Global Select Market,SPB | USA |
 |
Mesoblast Limited
MESO
|
$ 14.3 | -3.18 % | $ 17.3 B | Nasdaq Global Select Market | Australia |
 |
CEL-SCI Corporation
CVM
|
$ 1.39 | -1.42 % | $ 11.1 M | NYSE American,SPB | USA |
 |
Inventiva S.A.
IVA
|
$ 3.88 | -3.72 % | $ 232 M | Nasdaq Global Market | France |
 |
MeiraGTx Holdings plc
MGTX
|
$ 9.41 | -1.16 % | $ 757 M | Nasdaq Global Select Market | USA |
 |
Eton Pharmaceuticals
ETON
|
$ 50.68 | -0.53 % | $ 1.36 B | Nasdaq Global Market | USA |
 |
IDEAYA Biosciences
IDYA
|
$ 32.29 | 3.06 % | $ 2.86 B | Nasdaq Global Select Market | USA |
 |
Lantern Pharma
LTRN
|
$ 0.58 | -3.6 % | $ 6.32 M | Nasdaq Global Select Market | USA |
 |
Foghorn Therapeutics
FHTX
|
$ 2.11 | -1.17 % | $ 133 M | Nasdaq Global Market | USA |
 |
Minerva Neurosciences
NERV
|
$ 2.51 | 6.81 % | $ 21.2 M | Nasdaq Global Market | USA |
 |
Kamada Ltd.
KMDA
|
$ 7.41 | 2.21 % | $ 427 M | Nasdaq Global Select Market | Israel |
 |
Neurocrine Biosciences
NBIX
|
$ 166.08 | 0.75 % | $ 16.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Nanobiotix S.A.
NBTX
|
$ 29.58 | 3.57 % | $ 1.41 T | Nasdaq Global Select Market | France |
 |
Mereo BioPharma Group plc
MREO
|
$ 0.3 | 4.78 % | $ 239 M | Nasdaq Global Select Market |  Britain |
 |
Maravai LifeSciences Holdings
MRVI
|
$ 7.73 | 5.7 % | $ 1.12 B | Nasdaq Global Select Market | USA |
 |
Lexicon Pharmaceuticals
LXRX
|
$ 1.49 | 1.71 % | $ 541 M | Nasdaq Global Select Market | USA |
 |
Moleculin Biotech
MBRX
|
$ 8.47 | 2.05 % | $ 10 M | Nasdaq Global Select Market | USA |
 |
Nurix Therapeutics
NRIX
|
$ 15.72 | -39.12 % | $ 1.36 B | Nasdaq Global Select Market,SPB | USA |
 |
Nkarta
NKTX
|
$ 1.73 | 12.75 % | $ 128 M | Nasdaq Global Select Market | USA |
 |
MacroGenics
MGNX
|
$ 2.31 | -0.86 % | $ 146 M | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.